CSF3 and acute graft versus host disease: In the multivariate analysis, early initiation of G‐CSF (Days 0–4) was significantly associated with a higher risk of grades II–IV acute GVHD following CBT compared to those not receiving it (HR 1.33, 95% CI 1.09–1.61, p = .003).